Notch1 inhibition could potently prevent inactive FBXW7‐induced melanoma tumorigenesis, rendering Notch signaling as a promising therapeutic target in the subset of melanoma patients harboring FBXW7 mutations 45. This evidence concerns the gene NOTCH1 and melanoma.